Madrid, Spain: Cannabis’ active components show promise in halting the progression of certain neurodegerative disorders and should be evaluated in clinical trials, according to a review published online in the British Journal of Pharmacology. An international...
Evaluation of the neuroprotective effect of cannabinoids in a rat model of Parkinson’s disease: importance of antioxidant and cannabinoid receptor-independent properties. Abstract We have recently demonstrated that two plant-derived cannabinoids,...
STANFORD, Calif. — Marijuana-like chemicals in the brain may point to a treatment for the debilitating condition of Parkinson’s disease. In a study published in the Feb. 8 issue of Nature, researchers from the Stanford University School of Medicine report that...
A treatment for Parkinson’s disease has been dramatically improved by boosting the levels of natural marijuana-like chemicals in the brain. Researchers combined a drug used to treat patients with another that prevents the breakdown of substances called...
ScienceDaily – Cannabis (marijuana) is the most widely produced plant-based illicit drug worldwide and the illegal drug most frequently used in Europe. Its use increased in almost all EU countries during the 1990s, in particular among young people, including...
